Compounds > arabinofuranosyluracil

arabinofuranosyluracil and Thrombopenia

arabinofuranosyluracil has been researched along with Thrombopenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cleary, SM; Howell, SB; Kirmani, S; Mowry, J; Zimm, S1
Griffin, JD; Kufe, DW; Spriggs, DR1

Other Studies

2 other study(ies) available for arabinofuranosyluracil and Thrombopenia

ArticleYear
Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:6

    Topics: Adult; Aged; Arabinofuranosyluracil; Ascitic Fluid; Colonic Neoplasms; Cytarabine; Female; Humans; Infusion Pumps, Implantable; Infusions, Parenteral; Leukopenia; Metabolic Clearance Rate; Middle Aged; Ovarian Neoplasms; Peritonitis; Thrombocytopenia; Time Factors

1990
Pharmacologic studies of low-dose and high-dose continuous infusion cytosine arabinoside.
    Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1

    Topics: Adult; Aged; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Replicon; Thrombocytopenia

1987